61755-0054 LYNOZYFIC - CanMED: NDC

Product NDC:

61755-0054

Brand Name:

LYNOZYFIC

Generic Name:

Linvoseltamab-gcpt

Dosage Form Name:

INJECTION, SOLUTION, CONCENTRATE

Administration Route:

Intravenous

Substances:

Name: LINVOSELTAMAB

Strength: 5.0

Unit: mg/2.5mL

Packages:

Code: 61755-0054-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-054-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE (61755-054-00)

Effective Date: July 2, 2025

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Bispecific Antibody

Minor Class:

BCMA, CD3

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox